L830-0076 Screening compound: 3-[3-(2-methyl-1,3-thiazol-4-yl)phenyl]-5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazole

L830-0076 Screening compound: 3-[3-(2-methyl-1,3-thiazol-4-yl)phenyl]-5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazole
L830-0076 Screening compound: 3-[3-(2-methyl-1,3-thiazol-4-yl)phenyl]-5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound L830-0076
3-[3-(2-methyl-1,3-thiazol-4-yl)phenyl]-5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L830-0076

Molecular Formula

C17H16N4O2S (C17 H16 N4 O2 S)

Compound Name

3-[3-(2-methyl-1,3-thiazol-4-yl)phenyl]-5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazole

IUPAC name

3-[3-(2-methyl-13-thiazol-4-yl)phenyl]-5-(pyrrolidine-1-carbonyl)-124-oxadiazole

SMILES

Cc1nc(-c2cc(-c3noc(C(N4CCCC4)=O)n3)ccc2)cs1

InChI

InChI=1S/C17H16N4O2S/c1-11-18-14(10-24-11)12-5-4-6-13(9-12)15-19-16(23-20-15)17(22)21-7-2-3-8-21/h4-6,9-10H,2-3,7-8H2,1H3

InChI Key

QTZOIAGTPNHZPV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478776

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

340.41

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.711

Distribution Coefficient, logD

3.711

Water Solubility, LogSw

-3.91

Polar Surface Area

58.470

Acid Dissociation Constant (pKa)

27.95

Base Dissociation Constant (pKb)

2.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.40

L830-0076 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Immunological Library (6760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L830-0076 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L830-0076?
Check Price and Availability of L830-0076, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L830-0076 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L830-0076
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L830-0076
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L830-0076 available by request